Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ZYMERGEN INC.

(ZY)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Zymergen : Shares Fall to Lowest Level Since August Amid Low Trading Volume

10/06/2021 | 02:53pm EST


ę MT Newswires 2021
All news about ZYMERGEN INC.
11/22INSIDER BUY : Zymergen
MT
11/15ZYMERGEN INC. Management's Discussion and Analysis of Financial Condition and Results ..
AQ
11/11The Law Offices of Frank R. Cruz Announces Investigation of Zymergen Inc. (ZY) on Behal..
BU
11/10Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigati..
BU
11/03ZYMERGEN : Q3 Earnings Snapshot
AQ
11/03Zymergen Reports Preliminary Third Quarter 2021 Financial Results and Provides Business..
PU
11/03Earnings Flash (ZY) ZYMERGEN Reports Q3 Revenue $4.1M, vs. Street Est of $3.41M
MT
11/03Zymergen Reports Preliminary Third Quarter 2021 Financial Results and Provides Business..
AQ
10/26Zymergen to Report Third Quarter 2021 Financial Results on November 3, 2021
GL
10/21ZYMERGEN INC. : Entry into a Material Definitive Agreement, Costs Associated with Exit or ..
AQ
More news
Analyst Recommendations on ZYMERGEN INC.
More recommendations
Financials (USD)
Sales 2021 16,9 M - -
Net income 2021 -372 M - -
Net cash 2021 313 M - -
P/E ratio 2021 -2,07x
Yield 2021 -
Capitalization 972 M 972 M -
EV / Sales 2021 38,9x
EV / Sales 2022 53,8x
Nbr of Employees 758
Free-Float 90,7%
Chart ZYMERGEN INC.
Duration : Period :
Zymergen Inc. Technical Analysis Chart | ZY | US98985X1000 | MarketScreener
Technical analysis trends ZYMERGEN INC.
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus UNDERPERFORM
Number of Analysts 7
Last Close Price 9,49 $
Average target price 9,50 $
Spread / Average Target 0,11%
EPS Revisions
Managers and Directors
Jay T. Flatley Chairman & Chief Executive Officer
Enakshi Singh Chief Financial Officer
Zachariah Serber Director & Chief Science Officer
Jed Dean Vice President-Operations & Engineering
Aaron Kimball Chief Technology Officer
Sector and Competitors
1st jan.Capi. (M$)
ZYMERGEN INC.0.00%972
SHIN-ETSU CHEMICAL CO., LTD.5.49%69 534
BASF SE-10.41%60 017
DUPONT DE NEMOURS, INC.8.34%39 915
ROYAL DSM N.V.36.22%36 863
PIDILITE INDUSTRIES LIMITED25.45%14 988